Item 8.01 Other Events.
On September 10, 2021, Adagio Therapeutics, Inc. (the "Company") issued a press
release entitled "Adagio Therapeutics Announces Expansion of Patient Population
in Global Phase 2/3 Clinical Trial of ADG20 for the Prevention of COVID-19." The
full text of the press release is attached as Exhibit 99.1 to this Current
Report on Form 8-K.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit
No. Description
99.1 Press release, dated September 10, 2021.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses